Issue 40, 2023

Correction: Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis

Abstract

Correction for ‘Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis’ by Zhigao Yi et al., J. Mater. Chem. B, 2016, 4, 2715–2722, https://doi.org/10.1039/C5TB02375K.

Associated articles

Article information

Article type
Correction
Submitted
04 Oct 2023
Accepted
04 Oct 2023
First published
10 Oct 2023
This article is Open Access
Creative Commons BY license

J. Mater. Chem. B, 2023,11, 9765-9765

Correction: Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis

Z. Yi, X. Li, W. Lu, H. Liu, S. Zeng and J. Hao, J. Mater. Chem. B, 2023, 11, 9765 DOI: 10.1039/D3TB90192K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements